ArticleInfection2026
Geospatial analysis of open-source intelligence data to early detect laboratory-acquired infections, using the 2019 brucellosis laboratory leak in China as a case study.
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to use geospatial analysis to retrospectively determine whether earlier detection of the 2019 brucellosis laboratory leak in China could have been achieved using open-source intelligence data.
methodsWe used open-source intelligence data of brucellosis outbreaks from EPIWATCH
resultsThe central Gansu province, where the 2019 laboratory leak occurred, has China's densest signal of brucellosis outbreaks. In the multiple ring buffer analysis, outbreak signals were identified within a five-km radius of the Zhongmu Lanzhou Biopharmaceutical Plant Laboratory (ZLBPL) with an event date in July 2019. This compares to the official identification date of 6 December 2019. We identified 10,528 cases among 68,571 tests associated with the 2019 ZLBPL leak. This matches the 10,528 cases recorded in official reports among 79,357 tests, with 1,604 seeking medical treatment. This corresponds to a 13.3% test-positive rate among suspected cases and a 15.2% rate of medical treatment among confirmed cases.
conclusionA prolonged brucellosis laboratory leak occurred in China, with a delay of nearly six months before formal acknowledgment was received from local authorities. Geospatial analysis of open-source intelligence data identified the outbreak early, the likely source and a nearby laboratory affected by the outbreak.
Indexed as
Identifiers
41085603What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.